
Glioblastoma breakthrough: 40-year-old dad is brain cancer-free after groundbreaking immunotherapy trial
How?
Read on to know more.
What happened?
In October 2022, 40-year-old Ben Trotman was diagnosed with terminal glioblastoma, the most common and deadliest form of brain cancer that typically carries a grim prognosis with a median survival of just 12–18 months. Yet, over two years after receiving a single dose of ipilimumab before standard care, Trotman reportedly remains cancer-free and healthy as ever.
Under the care of consultant oncologist Dr. Paul Mulholland at UCLH (University College London Hospital), Trotman became part of an NHS-funded trial that administers ipilimumab, a checkpoint inhibitor designed to boost the immune system, before traditional surgery, radiotherapy, and chemotherapy.
Two years later, his scans show no signs of recurrence, an unprecedented outcome in glioblastoma treatment.
The medical marvel
The new clinical trial for the most deadly type of brain cancer, glioblastoma, which helped Ben with another shot at life, is looking for patients to join after an incredible success story. Organized by the NHS, this study aims to enroll 16 people over 18 months and is dedicated to Baroness Margaret McDonagh, who lost her battle with the disease.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Villas For Sale in Dubai Might Surprise You
Dubai villas | search ads
Get Deals
Undo
Patients diagnosed with glioblastoma will receive an immunotherapy drug called ipilimumab before starting standard treatments, making the most of their immune systems when they are at their strongest.
The trial is being led by experts at University College London Hospital's National Hospital for Neurology and Neurosurgery. It follows a previous study with the same drug, which had to close because not enough patients joined.
The trial honors the late Baroness Margaret McDonagh's memory and, like Trotman, participants receive ipilimumab to prime their immune defenses, with hopes of replicating his reassuring response.
Ipilimumab: The key behind the breakthrough
Ipilimumab is a monoclonal antibody that blocks CTLA-4, an immune checkpoint. In cancers like melanoma, it enhances T-cell activity, enabling the body to attack tumors. When used before standard glioblastoma therapy, it primes the immune system to better target cancer cells.
In Trotman's case, it appears to have either eradicated or dramatically controlled his tumor, an outcome never before reported in this context.
This 'window-of-opportunity' pre-treatment approach is groundbreaking. By delivering immunotherapy before surgery, it maximizes immune activation and potentially aids post-operative cancer control, a novel strategy in glioblastoma care.
What is glioblastoma?
Glioblastoma, previously known as glioblastoma multiforme or GBM, is the most common and aggressive type of primary brain cancer in adults.
Glioblastoma originates from astrocytes, a type of glial cell that supports nerve cells in the brain and spinal cord. Glioblastoma is classified as a Grade IV tumor, meaning it's highly aggressive, grows rapidly, and infiltrates surrounding brain tissue. The exact cause of most glioblastomas is unknown. However, it is understood that the disease develops when brain cells undergo DNA mutations that cause them to grow and multiply uncontrollably.
The prognosis for glioblastoma is generally poor, with a median survival of about 12-18 months after diagnosis. The five-year survival rate is around 5%, meaning about 5% of patients are still alive five years after their diagnosis. Glioblastoma almost always recurs despite maximal treatment.
Hence, Trotman's cancer-free scans more than two years post-treatment represent a hopeful breakthrough. It suggests that bolstering immune readiness before conventional treatment might overcome glioblastoma's defenses.
The success story
The success story comes from Ben Trotman, who was diagnosed in October 2022 at the age of 40. Now, at 43, two years and eight months after his treatment, his scans are clear, and there are no traces of the tumor.
Dr. Paul Mulholland, the consultant medical oncologist who is leading this new trial and treated Ben, as reported by The Independent, shared, 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans.
We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay – and it has so far, which we are delighted to see.
'
Ben's life has changed significantly since his diagnosis; he got married to Emily just two months after receiving the immunotherapy treatment, and in April, they welcomed their daughter, Mabel. Emily expressed the emotional toll of Ben's diagnosis, saying, 'Getting this diagnosis was the most traumatic experience.
We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.
Had we not met Dr. Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.'
After the immunotherapy, Ben went on to have the standard treatments of radiotherapy and chemotherapy. He continues to have quarterly scans, which remain clear. Ben reflected on their journey, stating, 'We obviously don't know what the future holds, but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and me a bit of hope.
We are focused on rebuilding the life we thought we had lost and enjoying being parents.
'
Dame Siobhain McDonagh MP led a successful fundraising campaign that gathered over £1 million to support this new trial. Her sister, Baroness McDonagh, sadly passed away from glioblastoma in 2023. Dame Siobhain shared, 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma.
Changing this was Margaret's final campaign and one that I have continued in her memory.
I am so grateful to the many people who knew and respected Margaret, who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.'
Dr. Mulholland is also thankful for Margaret and Siobhain's dedication, stating, 'When I met Margaret, she said to me, 'What can I do to support you to cure this disease?'.
I am incredibly grateful to her and to Siobhain, whose campaigning and fundraising in her sister's memory have led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis.
The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy.
We're taking everything we have learned from previous trials into this new study, and we are already planning follow-on trials. My aim is to find a cure for glioblastoma.'
What's ahead?
Led by Dr. Mulholland, the trial is expanding enrollment, aiming to confirm both safety and effectiveness. Currently, the National Brain Appeal is funding two positions to support Dr. Mulholland's vital research. The treatment will take place at the NIHR UCLH's Clinical Research Facility and the National Hospital for Neurology and Neurosurgery. Patients who are interested in participating in the new Win-Glio trial should discuss it with their consultant.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
‘NASA is under attack': Massive NASA layoffs see 20% staff fired amid Donald Trump's fund cuts; nationwide protests erupt
Image: Nearly 20% of NASA's workforce — approximately 3,870 employees — have exited the agency following major funding cuts under the Trump administration's plan to downsize federal agencies. The layoffs stem from the Deferred Resignation Program, with officials describing the move as an effort to make NASA 'leaner and more efficient.' The decision has triggered widespread backlash from scientists, engineers, and space policy experts, who warn of serious risks to the agency's future missions. Nationwide protests erupted over the weekend, with current and former employees calling the move a direct threat to America's leadership in space. NASA fires thousands under federal downsizing drive The second round of the Deferred Resignation Program, which closed late Friday, saw roughly 3,000 resignations on top of 870 from the first wave of departures after Trump returned to office. Including regular attrition, NASA's workforce has shrunk from over 18,000 to around 14,000, marking a 20% reduction. Those resigning have been placed on administrative leave until their official exit. The move was orchestrated under the Department of Government Efficiency, currently led by Elon Musk. NASA insists that safety remains a top priority, yet internal experts are raising alarms about the loss of institutional knowledge and highly skilled personnel. With Mars and Moon missions central to the Trump administration's ambitions, critics argue these cuts threaten mission readiness. Former NASA officials and space industry leaders are questioning the agency's capacity to manage complex space programs in the coming years. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Live Comfortably: 60m2 prefabricated bungalow for the elderly in Tebas Pre Fabricated Homes | Search Ads Search Now Undo Protests erupt over 'brain drain' and loss of legacy Protests have broken out in several cities including Houston, Washington D.C., and Cape Canaveral, where current and former NASA staff, union representatives, and supporters gathered to oppose the mass layoffs. A letter titled The Voyager Declaration, signed by hundreds of former employees, warns that irreplaceable expertise is being lost at a critical moment for U.S. space exploration. 'This is not streamlining,' one protestor said, 'this is sabotage.' Doubts over leadership as Trump's NASA pick falters Adding to the turmoil, NASA is still being led by an acting administrator after tech billionaire Jared Isaacman, Trump's initial nominee backed by Elon Musk, was rejected for the role. In the absence of permanent leadership, critics argue that the agency is navigating its most challenging transformation without a clear long-term vision or stable command structure.


Time of India
2 hours ago
- Time of India
Study unveils avian trove, documents 452 bird species across Telangana
1 2 3 4 5 6 Hyderabad: A newly published research paper by a professor from Osmania University (OU) has documented 452 species of birds across Telangana. It is said to be one of the most comprehensive avifaunal checklists ever compiled for the state. Published in the Journal of Threatened Taxa on July 26, the study by Chelmala Srinivasulu from OU and Sriram Reddy from Hyderabad Birding Pals offers insights into Telangana's bird diversity, including rare sightings and first records for India, such as the Spur-winged Lapwing. It also highlights the presence of globally threatened species like the critically endangered Indian Vulture and Lesser Florican, underscoring the region's importance for bird conservation. "Birds are excellent indicators of environmental health," said Srinivasulu, adding: "Our work not only corrects outdated records but also showcases Telangana's hidden biodiversity-rich areas from wetlands to forests, from grasslands to urban lakes." You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad Reddy, co-author, added, "This checklist is not just for scientists. It is for every nature lover, student, and amateur birder. We urge people from all walks of life to take up birdwatching, not just as a hobby, but as a meaningful connection to our natural heritage." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Official IQ Test: What is Your IQ? | Answer 30 Questions to Find Out IQ International Undo Researchers pointed out that the paper is the result of decades of field observations, historic record reviews, and community-contributed data. "Citizens must appreciate and protect the birds around them. Policymakers need to work in tandem with researchers and experts to prioritise habitat identification and conservation. Our bird diversity and populations are declining due to many direct and indirect threats. We must nurture a new generation of bird lovers," added Srinivasulu.


Time of India
3 hours ago
- Time of India
Furnish data on malnutrition in 4 weeks: HC tells MP govt
Bhopal: A division bench of the Madhya Pradesh High Court asked district collectors from across the state to file a status report on the malnutrition situation in their respective districts. The bench, comprising Chief Justice Sanjeev Sachdeva and Justice Vinay Saraf, gave four weeks for this purpose and issued notices to the state govt and the chief secretary in response to a Public Interest Litigation (PIL) moved by a resident of Jabalpur, Deepankar Singh. Singh, in his petition, said that there is an alarming situation in MP regarding malnutrition among its people, but the state govt keeps hiding this terrible state of affairs by 'manipulating' data. He requested the court to ask for a report on malnutrition from the state govt to know the actual state of malnutrition prevalent among the people in MP so that efforts could be made to tackle the menace of malnutrition, particularly among the children. He said that according to the Poshan Tracker-2.0 and National Health Survey report, MP stands second in the country in terms of malnutrition. Attributing this situation to poor implementation of schemes on health and nutrition, he said that weak, underweight, and stunted children are born in the state because of malnutrition. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You will never turn off your computer again. Undo He further said that CAG, in its report, referred to a massive scam in the transportation and quality of nutritious food, but there was no action on the part of the state govt. The petitioner said that among 66 lakh children in the age group of 0 to 6 years, 10 lakh are malnourished, and 1.36 lakh of them are severely malnourished. The prevalence of anaemia among women is 57%. It was also pointed out during the hearing that Rs 1.80 crore were paid as rent for anganwadi centres in Jabalpur district alone, but only a handful of children visit those centres. After the initial hearing, the court asked all the district collectors from across the state to furnish a report on the status of malnutrition in their respective districts within four weeks. Advocate Amit Singh Sengar and Atul Jain appeared in the case for the petitioner.